If you have additional questions, please contact PharmMD

1-866-850-4159

Q&A

Why is PharmMD calling my office?

Health plans and employers across the United States partner with PharmMD to help them identify and address gaps in care across their membership. If we’ve called you, one of your patients is part of this program and we’ve identified at least one gap. This could be associated with a chronic disease state and involve incorrect medications, a possible adverse drug-drug interactions or therapeutic alternatives. PharmMD also calls physician offices on behalf of members to coordinate medication refills or address other medication-related gaps identified during a recent medication review with them.

Q&A

I received a letter/fax from PharmMD, what am I supposed to do?

PharmMD letters/faxes are related to specific patient care gaps (see response above). If action is required, the letter/fax will explain what to do. You should include these documents in the patient’s chart for discussion during their next office visit. If you’d like to speak with a PharmMD clinician first, please call the number provided on the letter/fax.

Q&A

How do I get removed from your contact list?

PharmMD is a contracted partnership with your patient’s health plan or employer group, so questions about existing or future member-related communications are best answered by one of their representatives. Please call 1-866-850-4159 and we can help facilitate this.

Q&A

I received a fax/letter from PharmMD for a medication change – who should I contact?

You should contact the patient’s pharmacy to update the prescription or address a medication-related concern directly with patient. PharmMD has been designated to notify all those involved with the patient of recommended changes, but does not dispense medication.

How We Make an Impact

REAL CONSUMER STORIES

Ed has type 2 diabetes and is at risk for heart disease and/or stroke. PharmMD’s analytics identified a gap in statin usage for his diabetes and this prompted our nurse to reach out to Ed’s doctor. The doctor prescribed lovastatin to Ed and it addressed the quality issue.

Ed M.

David’s cholesterol medication refill was months overdue and during PharmMD’s CMR, he stated the discontinuation was due to receiving positive lab results. Our pharmacist convinced David the good lab results were a result of the medications, addressed the serious health risks with him and the consumer immediately refilled the medications.

David C.

Keith is in a long-term care center and was taking blood thinners warfarin and dabigatran as part of his daily regimen. PharmMD immediately contacted Keith's provider about the oversight. The provider agreed to discontinue one of the blood thinners. PharmMD's OptimizeMTM™ platform caught the therapy duplication preventing severe bleeding and other potentially life-threatening complications for this consumer.

Keith H.

Julie was taking a high-dosage of morphine for pain, but due to side-effects her physician changed medications to hydrocodone, oxycodone and acetaminophen. PharmMD analytics identified a acetaminophen dosage guideline issue, prompting our pharmacist to contact Julie’s physician to discuss alternatives and ultimately improved the chronic pain management.

Julie M.

Josh’s medication was changed from lisinopril to losartan for his hypertension. PharmMD analytics identified Josh hadn’t filled the lostaran which increased risk for stroke. Our clinician contacted Josh who was confused and followed up with his pharmacist and physician to close the gap.

Josh B.

Stephen was prescribed with lisinopril for high blood pressure but missed doses increasing risk for cardiac arrest. PharmMD’s analytics identified the risk and upon our clinician’s discussion with Stephen about his apparent memory issues, a pill organizer was facilitated ultimately improving adherence.

Stephen B.

Roberta is 67 and her muscle pain was being treated with methocarbamol, which increases the risk of falling for consumers over 65 or older. PharmMD analytics identified tizanidine as a safer alternative, alerting our nurse to discuss the gap with Roberta’s clinician prompting a medication change.

Roberta A.

Ida R. has type 2 diabetes and misunderstood how her insulin would regulate glucose release during the early dawn hours. PharmMD analytics identified insulin fill gaps that increased Ida's risk of complications and future hospitalizations. Upon our clinician intervening, Ida was educated about the importance of insulin and diabetes educational support. Ida returned to her prescribed care plan, improving her quality of care.

Ida

Mrs. Robbins’s heart disease requires simvastatin and clopidogrel to reduce heart attack and stroke risk. PharmMD’s medication adherence analytics prompted our pharmacist to discuss these risks. Mrs. Robbins supported the plan, improving quality and reducing her risk of hospitalization.

Mrs. Robbins

Margaret’s chronic asthma benefits from a rescue inhaler for flare-ups. PharmMD’s analytics showed a prescription gap and during PharmMD’s CMR discussion, our pharmacist discussed the issue with Margaret, prompting outreach to her doctor for an order to prevent asthma emergencies.

Margaret W.

Carla struggled with high blood pressure and her losartan prescription was out of refills. PharmMD’s pharmacist reached out to Carla due to medication adherence analytics identifying medication gaps and subsequently contacted the physician for the refill order and improved quality of care.

Carla S.